The purpose of this study was to assess whether the incidence of histopathologically confirmed condyloma and penile intraepithelial neoplasia (PeIN) and rates of genital HPV infection progression to these lesions differs by country (Brazil, Mexico and the U.S.). At each visit, lesions were biopsied and were categorized by pathologic diagnoses. The Linear Array genotyping method was used to identify HPV genotypes from genital swabs, while the INNO-LiPA HPV Genotyping Extra method was used for tissue specimens. Age-specific analyses were conducted for lesion incidence by country, with Kaplan-Meier estimation of cumulative incidence. The proportion of HPV infections that progressed to condyloma and PeIN, the median time to lesion development and the incidence rates were estimated by country. When comparing demographic and sexual characteristics across the three countries, sexual orientation (p 5 0.008) and lifetime number of female sexual partners (p < 0.0001) were differentially associated with lesion incidence in the three countries. Condyloma incidence in Brazil and the U.S. decreased with age, while incidence remained constant across the lifespan in Mexico. There were no differences by country and age for PeIN incidence. HPV types 6 and 11 were the most common types to progress to condyloma and HPV types 16, 6 and 11 were the most common types to progress to PeIN in all three countries. The continuous risk of condyloma and PeIN across all age groups and countries in this study emphasizes the need to ensure that strong HPV immunity, such as that obtained through vaccination, is maintained across the lifespan of men.
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Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide. The majority of those infected with HPV are able to clear their infections naturally; however, a proportion of infections progress to penile, oropharyngeal and anal cancers in men. 1 At the male genitals, HPV can cause two types of external genital lesions (EGLs): condylomata acuminata, commonly referred to as condyloma or genital warts and penile intraepithelial neoplasia (PeIN), believed to be a precursor to HPV-related penile cancer. The HPV genotypes that are most frequently detected in condyloma are HPV 6 and 11 (detected in 96-100% of all condyloma). 2, 3 Incidence of condyloma in men has been shown to be associated with younger age (<30 years) and a high lifetime number of sexual partners. 4, 5 Condyloma has a high likelihood of recurrence; therefore, treatment is associated with high medical expenditures. 6 Thus, determining condyloma incidence, the HPV types detected in condyloma and the rate of HPV infection progression to disease is clinically important and contributes significantly to cost-effectiveness modeling of prevention and treatment interventions in each country.
While penile cancer is considered a rare cancer with 22,000 estimated cases per year worldwide, it is associated with a high morbidity and mortality. 7 The incidence of penile cancer varies based on geographical location with lowest rates in the U.S. (1/100,000 person-years) and highest rates in Brazil (5/100,000 person-years). 8, 9 Penile cancer is most commonly diagnosed in 50-70 year olds and is associated with lack of circumcision and sexual behaviors associated with HPV acquisition. [9] [10] [11] A recent study of PeIN and invasive penile cancer from 25 countries detected HPV in 87% of PeIN and 33% of penile cancers. 12 Similar to other studies, HPV 16 was the predominant type detected in PeIN lesions. [13] [14] [15] [16] [17] [18] We recently reported condyloma and PeIN incidence rates among men participating in the multinational HPV Infection in Men (HIM) Study. 16 We also estimated the rate of HPV infection progression to both of these lesion types, pooling data across the three participating countries. 19 Our goal for this analysis was to estimate EGL incidence and the rate of HPV progression to EGL by country.
Material and Methods
Study design and population 
Genital specimen collection and HPV detection
Participants underwent a clinical examination at each visit. Using saline prewetted Dacron swabs, genital specimens were collected from the coronal sulcus/glans penis, penile shaft and scrotum. 21 These specimens were combined into one sample per participant and archived. Specimens underwent DNA extraction (Qiagen Media Kit), PCR analysis and HPV genotyping (Roche Linear Array). 22 To best set policy for protecting men against HPV, it is valuable to understand patterns of HPV-related disease. These authors tabulated incidence data from Brazil, Mexico and the United States to find out how often men develop external genital lesions, such as genital warts and penile intraepithelial neoplasia (PeIN). In all three countries, men continued to develop HPV-related lesions at older ages, 45-70, suggesting that it might be wise to keep up immunizations throughout adulthood. HPV types 16, 6 and 11 were the most likely to progress to lesions. biopsy cohort baseline date to the date of first EGL detection. Person-time incidence and 95% confidence intervals (CIs) were calculated based on the number of events modeled as a Poisson variable for the total number of person-months. Incidence rate ratios (IRR) and 95% CIs were also calculated based on Poisson assumption comparing incidence rates between countries. EGL incidence Kaplan-Meier curves were generated and EGL incidence over time by country was compared using the log-rank test. The cumulative incidence of developing an EGL within the first 12 months of follow-up was also estimated by country using the Kaplan-Meier method.
Progression of HPV infection to EGL. Men with an incident or prevalent genital HPV infection and without a prevalent condyloma or PeIN lesion at the biopsy protocol baseline visit were included in analyses designed to assess the rate of progression and the proportion of infections progressing to disease by country. HPV infection was reported by genotype or group (any, HR-HPV, LR-HPV and vaccine [HPV types 6/11/16/18]). The classification of any HPV type was defined as a positive test result for at least one of the 25 HPV genotypes that can be detected by both Linear Array and INNOLiPA. HPV infections with single or multiple HR-HPV types were classified as HR and those with at least one LR-HPV type were classified as low risk.
The time-to-event approach was applied to assess the time from type-specific genital HPV positivity to incidence of an EGL harboring the same HPV type by country. The analytical unit was infection. HPV genital infections that did not progress to EGL were censored at the last visit. The 6-, 12-and 24-month cumulative incidence of EGLs and median time to EGL development for individual genital HPV types was estimated using the Kaplan-Meier method. Multiple HPV types could be detected in a single EGL and a man could develop multiple EGLs. For grouped genital HPV infections, we adjusted for within-subject correlation using the clustered Kaplan-Meier method, 25 as men could have been infected with multiple HPV types within a defined group. The overall EGL incidence rate during the study period was also calculated. IRR and 95% CIs were also calculated, based on Poisson CIs comparing incidence rates between countries.
Results

EGL incidence
The HIM study biopsy cohort included 3012 men aged 18-73 years. Of these, 229 men developed an incident EGL during the study period. Men could develop multiple types of EGLs and these EGLs were primarily diagnosed as condyloma (n 5 162), PeIN (n 5 11), or non-HPV-related EGL (n 5 75). EGL incidence was higher among men from Mexico (42.0%) compared with men from Brazil (31.9%) and the U.S. (25.8%; p 5 0.001). In Brazil, EGL incidence was associated with age (p 5 0.006) and marital status (p 5 0.01; Table  1 ). EGL incidence in Mexico was associated with sexual orientation (p 5 0.007) and number of female (p 5 0.003) and number of male sexual partners (p 5 0.006, Table 1 ). In the U.S., EGL incidence was associated with circumcision status (p 5 0.04) and marginally associated with the number of female sexual partners (p 5 0.06; Table 1 ). When comparing demographic and sexual characteristics across the three countries, sexual orientation (p 5 0.008) and total number of female sexual partners (p < 0.0001) were differentially associated with EGL incidence across the three countries. (Table 1 , global p-value).
Condyloma incidence, stratified by age group and country, is presented in Table 2 . No differences by country were observed when comparing condyloma incidence rates within age categories (18-30, 31-44 and 45-73 years; Table 2 ). When examining incidence rates by country, a significant decline in the 12-month cumulative condyloma incidence with age was observed in Brazil (3.1, 1.9 and 0.9% for ages 18-30, 31-44 and 45-73 years, respectively; p 5 0.02 across the entire follow-up period, Table 2 , Supplementary Figure  1a) . In contrast, among men from Mexico, the 12-month cumulative condyloma incidence remained constant with increasing age (2.7, 2.4 and 2.5% for ages 18-30, 31-44 and 45-73 years, respectively; p 5 0.64 across the entire follow-up period, Table 2 , Supplementary Figure 1b) . In the U.S. the 12-month cumulative condyloma incidence was marginally statistically higher among men <45 years of age compared with older men (4.6 and 5.2% among men 18-30 and 31-44 years old, respectively and 1.4% among men 45-73 years old, p 5 0.06 Abbreviations: CI: confidence interval; PeIN: penile intraepithelial neoplasia (I-III); NE: not estimable. 1 Includes both condyloma and suggestive of condyloma categories;. 2 Specified as the number of cases per 100 person-years;. 3 Determined using the log-rank test and corresponds to overall differences in EGL incidence across the entire follow-up period by age group in each country. p values < 0.05 are considered statistically significant.
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across the entire follow-up period, Table 2 , Supplementary Figure 1c) . Similar to what was observed for condyloma, no differences by country were observed when comparing PeIN incidence rates within age categories (Table 2) . Within each country, there were no statistically significant differences in incidence by age group (Table 2) . Among the 15 prevalent and incident PeIN lesions that were genotyped, 100% were HPV-positive and 80.0% were positive for 1 HR-HPV genotypes. HPV 16 was detected in eight (53.3%) of the PeIN lesions and men from Mexico had the highest number of HPV 16-positive PeIN lesions (n 5 4). Although all of the PeIN lesions detected in the U.S. were HPV 16-positive, there were only two incident PeIN lesions. In contrast, low-risk HPV types were found only in 53.3% of PeIN lesions (20.0% were positive for HPV 6 and 26.7% were positive for HPV 11; Table 3 ). While low-risk types were mainly found in PeIN lesions as co-infections with a high-risk genotype, HPV 6 was found as a single infection in one PeINI and one PeINIII lesion, both of which occurred in men from Brazil. HPV 11 was found as a single infection in one PeINI lesion from Mexico (Table 3) . Two incident PeIN lesions contained HPV types not targeted by either the quadrivalent or the nonavalent vaccine: HPV 39/68/73 (PeINI, Brazil) and HPV 51 (PeINII, Mexico).
Progression of HPV infection to EGL
Among the 3012 men, 1889 (555 in the U.S., 815 in Brazil, 519 in Mexico) had a prevalent or incident genital HPV infection during follow-up and were included in the analysis examining progression of HPV infection to EGL. These 1889 men had a total of 4736 genital HPV infections detected during follow-up (1400 in US, 2232 in Brazil, 1104 in Mexico). Among men with an HPV infection, 4% of men from Brazil, 6% in Mexico and 5% in the U.S. progressed to an EGL with the same HPV type detected in the lesion.
Considering HPV infection as the unit of analysis, genital HPV 6 progression to an HPV 6-positive condyloma among men from Brazil was 15.7% (18/115) with a median time from infection to condyloma of 9.0 months. Among men from Mexico, 31.2% (24/77) of infections progressed to condyloma, with a median progression time of 14.3 months. Among men from the U.S., 28.0% (23/82) of infections progressed to condyloma, with a median progression time of 6.9 months (Table 4) . HPV 6 infections were more likely to progress to HPV 6-positive condyloma in men from the US (IRR 2.0, 95% CI 1.1-3.8) and Mexico (IRR 2.1, 95% CI 1.1-3.8) compared with men from Brazil ( Table 4 , Supplementary  Figure 1d ). For HPV 11 genital infections, 15.7, 28.6 and 29.4% progressed to HPV 11-positive condyloma among 2 Lesions with data present in this column were included in the HPV progression to EGL analyses. HPV genotyping at the genitals was detected through Linear Array. HPV genotypes that were detected within the lesion are in bold. Lesions designated as NE did not have the HPV detected within the lesion prior to lesion development. 3 Both specimens were from a single participant and underwent diagnostic analysis. 4 Both specimens were from a single participant and underwent diagnostic analysis.
men from Brazil, Mexico and the U.S., respectively ( Table 4) . The HPV 11-positive condyloma incidence rate among men with a prior HPV 11 infection did not significantly differ by country (Table 4 , Supplementary Figure 1e. ). <1% (9 of 4736) of genital HPV infections progressed to PeIN with the same HPV type detected in the lesion, with a median time from infection to PeIN of 6.7 months. One to two percent of genital HPV 16 infections progressed to an HPV 16-positive PeIN among men from each country (Table  5) . No other HR-HPV genital infections progressed to PeIN during follow-up. Three LR-HPV types at the genitals (6, 11 and 73) progressed to PeIN in Brazil and Mexico. The HPV 16-positive PeIN incidence rate among men with a prior HPV 16 infection did not significantly differ by country (Table 5 ).
Discussion
We compared EGL incidence and progression of HPV infection to EGL across three countries: the U.S., Brazil and Mexico. While there were country-specific differences, several findings remained consistent across the three countries. The condyloma incidence rate decreased with increasing age in Brazil and U.S. but remained fairly constant across the lifespan in Mexico. Men aged 45-70 years in all three countries continued to develop condyloma during follow-up highlighting that men remain susceptible to acquiring new HPVrelated EGLs throughout their lives. HPV types 6 and 11 were the most common types to progress to condyloma and HPV types 16, 6 and 11 were the most common types to progress to PeIN, consistent with previous literature. 12, [26] [27] [28] The condyloma incidence rate was highest among men from the U.S. (1.90 per 100 person-years [p-y]) compared to men from Brazil (1.57 per 100 p-y) and Mexico (1.77 per 100 p-y), although the differences were not statistically significant. Condyloma incidence in the HIM Study was comparable to the placebo arm of the male quadrivalent HPV vaccine trial (IR 5 1.58 per 100 p-y) 29 and higher than incidence among men in England (IR 5 0.17 per 100 p-y), 30 Spain (IR 5 0.14 per 100 p-y) 31 and Germany (IR 5 0.18 per 100 py), 32 based on healthcare databases. The differences in 3 The genital HPV infection was used as the unit of analysis. 4 Follow-up time in months. 5 Incidence rate was calculated as cases per 1000 person-months. 6 Vaccine HPV types 6/11/16/18.
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progression between countries presented here may be due to actual biological differences by country or due to limitations with study design. Lesions that occurred at the same visit that HPV was detected were not included in the time-to-event analyses. For example, if HPV 6 was first detected at the 12-month visit and an HPV 6-positive condyloma was detected at the 12-month visit, we could not track the time from infection to condyloma. There were 37 lesions that occurred at the same visit where HPV infection was first detected, of which 30 of the 37 lesions occurred in Brazil (data not shown). Once infected with HPV 6 or 11, there was a rapid progression from infection to condyloma. We were therefore limited in our analyses, as the HIM Study and other HPV natural history studies generally conduct visits at six-month time intervals. Although PeIN was a rare event in this population, we were able to detect and genotype 15 prevalent and incident PeIN lesions. All PeIN lesions were HPV-positive and 80.0% were positive for 1 HR-HPV genotypes. A recent analysis of 85 penile HGSIL from 25 countries detected HPV in 87.1% of lesions, with the lowest HPV DNA prevalence in penile HGSIL in Latin America at 63.6%.
12 HPV 16 was detected in 8 of our PeIN specimens, all of which were HGSIL (8/11, 73.0%), which is similar to the HPV16 prevalence of 79.6% in HGSIL reported by Alemany et al.
12
Although HPV16 cumulative incidence was lowest among men from Mexico, they had the highest incidence rate for HPV16 infection progression to HPV16-positive PeIN. However, these differences in PeIN incidence rates were not significantly different, likely due to the small sample size. Additionally, three PeIN lesions contained only a single LR-HPV genotype (6 or 11), consistent with prior published results showing rare cases of LR-HPV types in HG precancerous anogenital lesions. 12, 33, 34 Strengths of this study include the clinical data from three countries with a large sample size of men followed for disease within each country, the occurrence of study visits every six months to allow for early detection of lesions and the use of biopsy tissue for HPV genotyping. 24 While the HIM Study contains men in three countries across a wide age range, we had a relatively small sample size to assess PeIN incidence, which limited our ability to observe differences by country. Men from Brazil, Mexico and the U.S. have a high burden of HPV infection 21 and condyloma. While condyloma incidence generally decreases with age, men remain susceptible to HPV and condyloma at older ages (>45 years). The continuous risk of EGLs across all age groups in this study emphasizes the need to ensure that vaccine-related immunity is retained across the lifespan of men. Globally, only five countries have national gender-neutral vaccine policies: the U.S., Austria, Australia, Israel and some provinces in Canada.
Results presented here indicate that men in Brazil and Mexico often have similar, if not higher HPV-related disease risk, compared with men from the U.S. and may benefit from similar policy measures. 
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